COVIFIND Trademark

Trademark Overview

On Friday, May 13, 2022, a trademark application was filed for COVIFIND with the United States Patent and Trademark Office. The USPTO has given the COVIFIND trademark a serial number of 79354110. The federal status of this trademark filing is REGISTERED as of Tuesday, March 5, 2024. This trademark is owned by MERIL DIAGNOSTICS PRIVATE LIMITED. The COVIFIND trademark is filed in the Medical Instrument Products category with the following description:

In vitro medical diagnostic apparatus for testing antigens to diagnose COVID-19 incorporating chemical reagents for medical purposes
covifind

General Information

Serial Number79354110
Word MarkCOVIFIND
Filing DateFriday, May 13, 2022
Status700 - REGISTERED
Status DateTuesday, March 5, 2024
Registration Number7318264
Registration DateTuesday, March 5, 2024
Mark Drawing5 - Drawing with word(s) / letter(s) / number(s) in Stylized form
Published for Opposition DateTuesday, December 19, 2023

Trademark Statements

Goods and ServicesIn vitro medical diagnostic apparatus for testing antigens to diagnose COVID-19 incorporating chemical reagents for medical purposes

Classification Information

International Class010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials.
US Class Codes026, 039, 044
Class Status Code6 - Active
Class Status DateFriday, November 4, 2022
Primary Code010
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameMERIL DIAGNOSTICS PRIVATE LIMITED
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressIN
Party NameMERIL DIAGNOSTICS PRIVATE LIMITED
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressIN
Party NameMERIL DIAGNOSTICS PRIVATE LIMITED
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressIN

Trademark Events

Event DateEvent Description
Thursday, November 3, 2022SN ASSIGNED FOR SECT 66A APPL FROM IB
Friday, November 4, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, November 8, 2022APPLICATION FILING RECEIPT MAILED
Friday, March 3, 2023ASSIGNED TO EXAMINER
Friday, March 10, 2023ASSIGNED TO EXAMINER
Tuesday, March 14, 2023ASSIGNED TO EXAMINER
Thursday, March 16, 2023NON-FINAL ACTION WRITTEN
Friday, March 17, 2023NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Friday, May 5, 2023REFUSAL PROCESSED BY MPU
Friday, May 5, 2023NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Wednesday, May 31, 2023REFUSAL PROCESSED BY IB
Sunday, November 5, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Sunday, November 5, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, November 6, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, November 10, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, November 29, 2023NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, November 29, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, November 29, 2023NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Tuesday, December 19, 2023NOTIFICATION PROCESSED BY IB
Tuesday, December 19, 2023PUBLISHED FOR OPPOSITION
Tuesday, December 19, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, March 5, 2024REGISTERED-PRINCIPAL REGISTER
Tuesday, March 5, 2024NOTICE OF REGISTRATION CONFIRMATION EMAILED
Thursday, June 6, 2024FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Thursday, June 6, 2024FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Thursday, June 6, 2024FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

Related Keywords

covifind medical incorporating chemical purposes covid reagents antigens diagnostic apparatus testing